[
  {
    "ts": "2025-12-30T11:08:59+00:00",
    "headline": "Novo and Lilly cut prices of weight-loss drugs in China",
    "summary": "<body><p>STORY: Novo Nordisk and Eli Lilly are lowering prices of their top-selling obesity drugs Wegovy and Mounjaro in China.</p><p>Novo did not give details on the new prices.</p><p>But media outlet Yicai reported earlier that list prices for the two highest dosages of Wegovy were cut by 48% in some Chinese provinces.</p><p>The Danish drug maker confirmed a price adjustment to Reuters in a statement.</p><p>Lilly did not immediately respond to a request for comment.</p><p>According to a WeChat account for a hospital in the eastern city of Nanjing posted late last week, prices for Lilly's Mounjaro would also decrease from January 1st.</p><p>Over 65% of China's population of around 1.4 billion could be overweight or obese by 2030.</p><p>And both drugmakers are competing with rivals in the rapidly growing market.</p><p>They also face challenges after Novo's patent on Wegovy's active ingredient semaglutide expires in 2026 in China and other important markets.</p><p>Novo slashed Wegovy prices by up to 37% in India last month, as it seeks to gain ground in another fast-emerging market.</p><p>Both Novo and Eli Lilly also agreed to cut U.S. prices in November.</p></body>",
    "url": "https://finance.yahoo.com/video/novo-lilly-cut-prices-weight-110859896.html",
    "source": "Reuters Videos",
    "provider": "yfinance",
    "raw": {
      "id": "11f698e7-a790-3c41-846b-4e911b543bf2",
      "content": {
        "id": "11f698e7-a790-3c41-846b-4e911b543bf2",
        "contentType": "VIDEO",
        "title": "Novo and Lilly cut prices of weight-loss drugs in China",
        "description": "<title><body><p>STORY: Novo Nordisk and Eli Lilly are lowering prices of their top-selling obesity drugs Wegovy and Mounjaro in China.</p><p>Novo did not give details on the new prices.</p><p>But media outlet Yicai reported earlier that list prices for the two highest dosages of Wegovy were cut by 48% in some Chinese provinces.</p><p>The Danish drug maker confirmed a price adjustment to Reuters in a statement.</p><p>Lilly did not immediately respond to a request for comment.</p><p>According to a WeChat account for a hospital in the eastern city of Nanjing posted late last week, prices for Lilly's Mounjaro would also decrease from January 1st.</p><p>Over 65% of China's population of around 1.4 billion could be overweight or obese by 2030.</p><p>And both drugmakers are competing with rivals in the rapidly growing market.</p><p>They also face challenges after Novo's patent on Wegovy's active ingredient semaglutide expires in 2026 in China and other important markets.</p><p>Novo slashed Wegovy prices by up to 37% in India last month, as it seeks to gain ground in another fast-emerging market.</p><p>Both Novo and Eli Lilly also agreed to cut U.S. prices in November.</p></body></title>",
        "summary": "<body><p>STORY: Novo Nordisk and Eli Lilly are lowering prices of their top-selling obesity drugs Wegovy and Mounjaro in China.</p><p>Novo did not give details on the new prices.</p><p>But media outlet Yicai reported earlier that list prices for the two highest dosages of Wegovy were cut by 48% in some Chinese provinces.</p><p>The Danish drug maker confirmed a price adjustment to Reuters in a statement.</p><p>Lilly did not immediately respond to a request for comment.</p><p>According to a WeChat account for a hospital in the eastern city of Nanjing posted late last week, prices for Lilly's Mounjaro would also decrease from January 1st.</p><p>Over 65% of China's population of around 1.4 billion could be overweight or obese by 2030.</p><p>And both drugmakers are competing with rivals in the rapidly growing market.</p><p>They also face challenges after Novo's patent on Wegovy's active ingredient semaglutide expires in 2026 in China and other important markets.</p><p>Novo slashed Wegovy prices by up to 37% in India last month, as it seeks to gain ground in another fast-emerging market.</p><p>Both Novo and Eli Lilly also agreed to cut U.S. prices in November.</p></body>",
        "pubDate": "2025-12-30T11:08:59Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/uu/api/res/1.2/L3bMGCLziNGFt4r9zF9hCg--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://cf-images.us-east-1.prod.boltdns.net/v1/jit/6415665815001/720ad5bd-ff67-4b07-8cae-395a53dbc4f6/main/1280x720/41s141ms/match/image.jpg",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/x2_yqJ4TqSveAjEc3LPELQ--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://cf-images.us-east-1.prod.boltdns.net/v1/jit/6415665815001/720ad5bd-ff67-4b07-8cae-395a53dbc4f6/main/1280x720/41s141ms/match/image.jpg.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CeH1XSYpHWXPvdVoeml0iw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://cf-images.us-east-1.prod.boltdns.net/v1/jit/6415665815001/720ad5bd-ff67-4b07-8cae-395a53dbc4f6/main/1280x720/41s141ms/match/image.jpg.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters Videos",
          "url": "http://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/novo-lilly-cut-prices-weight-110859896.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/novo-lilly-cut-prices-weight-110859896.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-30T14:49:18+00:00",
    "headline": "Novo Nordisk and Eli Lilly Slash Obesity Drug Prices in China",
    "summary": "Lower costs aim to expand access in a fast-growing weight-loss market.",
    "url": "https://finance.yahoo.com/news/novo-nordisk-eli-lilly-slash-144918885.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "fe1e6aa5-aeea-37e9-a33c-aeac11509d68",
      "content": {
        "id": "fe1e6aa5-aeea-37e9-a33c-aeac11509d68",
        "contentType": "STORY",
        "title": "Novo Nordisk and Eli Lilly Slash Obesity Drug Prices in China",
        "description": "",
        "summary": "Lower costs aim to expand access in a fast-growing weight-loss market.",
        "pubDate": "2025-12-30T14:49:18Z",
        "displayTime": "2025-12-30T14:49:18Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/607644c1b912fd342c4a01abf25ed2ac",
          "originalWidth": 4800,
          "originalHeight": 3200,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dJZiq6ZXT1lPk38oaPwUng--~B/aD0zMjAwO3c9NDgwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/us.finance.gurufocus/607644c1b912fd342c4a01abf25ed2ac.cf.webp",
              "width": 4800,
              "height": 3200,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/R2ZHBTsTFBdZ50fR91UiNQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/607644c1b912fd342c4a01abf25ed2ac.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-eli-lilly-slash-144918885.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-eli-lilly-slash-144918885.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "CHJTF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-30T16:57:22+00:00",
    "headline": "Eli Lilly and Novo Nordisk Shares Dip After Cut Obesity Drug Prices in China",
    "summary": "Chinese Patients May See More Accessible Obesity Treatments After Pharma Price Moves",
    "url": "https://finance.yahoo.com/news/eli-lilly-novo-nordisk-shares-165722327.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "946a3a90-e305-30ad-ad4a-0c92623e5334",
      "content": {
        "id": "946a3a90-e305-30ad-ad4a-0c92623e5334",
        "contentType": "STORY",
        "title": "Eli Lilly and Novo Nordisk Shares Dip After Cut Obesity Drug Prices in China",
        "description": "",
        "summary": "Chinese Patients May See More Accessible Obesity Treatments After Pharma Price Moves",
        "pubDate": "2025-12-30T16:57:22Z",
        "displayTime": "2025-12-30T16:57:22Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/434a82c75d97e3a5a22898838638d64c",
          "originalWidth": 6382,
          "originalHeight": 4786,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Klfzvp39.soPeoaiqKcS3w--~B/aD00Nzg2O3c9NjM4MjthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/us.finance.gurufocus/434a82c75d97e3a5a22898838638d64c.cf.webp",
              "width": 6382,
              "height": 4786,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/W9CEpukOrGiNcDXN4UIi7Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/434a82c75d97e3a5a22898838638d64c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-novo-nordisk-shares-165722327.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-novo-nordisk-shares-165722327.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-30T16:05:00+00:00",
    "headline": "Can Amgen's MariTide Take on Leaders in the Obesity Space?",
    "summary": "AMGN's MariTide enters late-stage obesity trials with monthly dosing but faces rising competition as Eli Lilly and Novo Nordisk push oral GLP-1s.",
    "url": "https://finance.yahoo.com/news/amgens-maritide-leaders-obesity-space-160500785.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "a0a59990-690c-3564-b9d9-bd71aceb614e",
      "content": {
        "id": "a0a59990-690c-3564-b9d9-bd71aceb614e",
        "contentType": "STORY",
        "title": "Can Amgen's MariTide Take on Leaders in the Obesity Space?",
        "description": "",
        "summary": "AMGN's MariTide enters late-stage obesity trials with monthly dosing but faces rising competition as Eli Lilly and Novo Nordisk push oral GLP-1s.",
        "pubDate": "2025-12-30T16:05:00Z",
        "displayTime": "2025-12-30T16:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/7bc8bbeae2e0a87a69be234f543981cd",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cgmrsy.RXPZzY7yMaDwZPA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7bc8bbeae2e0a87a69be234f543981cd.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/HTl0ikZ844wasPEHHtWO1A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7bc8bbeae2e0a87a69be234f543981cd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgens-maritide-leaders-obesity-space-160500785.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgens-maritide-leaders-obesity-space-160500785.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]